Jim Simons Can Fite Bio Pharma Ltd. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.98 - $2.15 $91,536 - $200,820	-93,405 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.65 - $2.34 $154,118 - $218,567	93,405 New	93,405 $155,000
Q1 2021 May 13, 2021	SELL	$1.8 - $2.92 $214,009 - $347,170	-118,894 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.66 - $2.15 $175,739 - $227,614	105,867 Added 812.67%	118,894 $212,000
Q3 2020 Nov 13, 2020	BUY	$1.61 - $2.67 $20,973 - $34,782	13,027 New	13,027 $23,000
Q1 2020 May 14, 2020	SELL	$1.13 - $3.52 $36,591 - $113,984	-32,382 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.95 - $4.4 $63,144 - $142,480	32,382 New	32,382 $107,000

1.1K

Ticker CANF
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,191,500
Market Cap $54.7M
Description
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.